Kinomatic, an AI- and virtual reality-driven orthopedic surgery planning and recovery company, has raised $4 million in seed funding to accelerate development of its personalized approach to joint replacement care. The round was led by Waterline Ventures, with the company planning to use the investment to expand operations, grow its team, open a new office, and continue building its AI-enabled surgical planning and recovery optimization platform.

Founded in 2021 and headquartered in Arroyo Grande, California, Kinomatic is developing technology designed to improve outcomes for patients undergoing total knee and hip replacement procedures. The company combines artificial intelligence, virtual reality, custom 3D modeling, and patient recovery support to provide a more personalized experience before and after surgery.

Waterline Ventures led Kinomatic’s $4 million seed financing round. The investment firm focuses on supporting technology companies and entrepreneurs developing solutions with the potential to transform industries. Waterline Ventures’ investment will help Kinomatic scale its platform and expand its presence in the orthopedic healthcare market.

Kinomatic’s platform is designed to address challenges associated with traditional joint replacement procedures, where surgical planning and recovery programs have historically relied on generalized approaches. The company’s technology uses AI-enabled analysis and patient-specific data to help surgeons plan procedures based on individual anatomy and improve postoperative recovery experiences.

The company’s platform includes several components across the surgical journey. Kinomatic provides custom preoperative 3D modeling based on patient-specific measurements, allowing surgeons to visualize anatomy and plan procedures before entering the operating room. It also incorporates VR surgical simulation, enabling physicians to rehearse procedures using digital representations of a patient’s anatomy.

Beyond surgical preparation, Kinomatic focuses on postoperative recovery optimization and long-term outcomes tracking. The company aims to support patients after surgery through a concierge-style recovery experience designed to help improve rehabilitation and reduce challenges commonly associated with joint replacement recovery.

Kinomatic’s technology is focused particularly on total knee and hip replacement procedures, two of the most common orthopedic surgeries. The company believes that personalized planning and recovery support can help improve patient outcomes by accounting for individual differences in anatomy, biomechanics, and recovery needs.

The company reported that since its founding, it has achieved significant growth, including a sevenfold increase in revenue over four years and a fivefold expansion in provider relationships. Kinomatic has also reported a Net Promoter Score of 85, reflecting strong patient satisfaction with its care experience.

The funding comes as healthcare companies increasingly explore artificial intelligence as a tool for improving clinical decision-making, operational efficiency, and patient outcomes. In orthopedic care, AI technologies are being developed to support areas including surgical planning, implant selection, rehabilitation, and predictive analytics.

Kinomatic’s approach combines digital health technology with physician workflows rather than replacing clinical expertise. The company’s platform is designed to support surgeons by providing additional information and planning capabilities while maintaining physicians’ role in making treatment decisions.

As part of its growth plans, Kinomatic also announced the appointment of Dr. Andrew B. Wickline, MD, FAAOS, as chief medical officer. Dr. Wickline is a board-certified orthopedic surgeon known for developing opioid-sparing recovery protocols and founding March2aMillion, a national nonprofit initiative focused on surgeon education and reducing opioid dependency in orthopedic surgery.

Dr. Wickline’s role at Kinomatic will focus on advancing the company’s postoperative recovery programs and supporting the development of care protocols aimed at improving patient recovery following joint replacement procedures.

The company’s seed financing represents an important step in expanding its AI- and VR-driven healthcare platform. With additional resources, Kinomatic plans to continue developing its technology, increase provider partnerships, and expand access to personalized orthopedic surgery planning and recovery solutions.

The investment from Waterline Ventures positions Kinomatic to further its goal of creating a more individualized model for joint replacement care. By combining artificial intelligence, virtual reality, and patient-focused recovery support, the company is seeking to redefine how orthopedic procedures are planned and experienced by both surgeons and patients.

Related Articles